Lenalid 5/Lenalid 10/Lenalid 15/Lenalid 25 Dosage/Direction for Use

Take Lenalidomide (Lenalid) capsules exactly as prescribed.
Swallow Lenalidomide (Lenalid) capsules whole with water once a day. The patient should try to take it at about the same time each day.
Do not break, chew, or open the capsules.
It is important to remember that if the patient is being assisted with the medication, females who could become pregnant, or who plan to become pregnant can handle Lenalidomide (Lenalid) capsules if they are using latex gloves.
Lenalid 5/Lenalid 10/Lenalid 15/Lenalid 25: Multiple Myeloma: Starting dose: 25 mg daily on days 1-21 of 28 day cycles in combination with dexamethasone.
The doctor may change the dosage during treatment, and will continue therapy as long as the patient is responding to and tolerating Lenalidomide (Lenalid) capsules.
The patient will have regular blood tests during treatment with Lenalidomide (Lenalid) capsules. Patient should have their blood tested once every week during the first 2 cycles (8 weeks) of treatment, every 2 weeks during the third cycle, and at least monthly after that. The healthcare provider may adjust the patient dose of Lenalidomide (Lenalid) capsules or interrupt the treatment based on the results of the patient blood tests and, on the patient, general condition.
Lenalid 5/Lenalid 10: Myelodysplastic Syndrome: Starting dose: 10 mg daily on days 1-21 of 28-day cycles.
The doctor may change the dosage during treatment, and will decide the total duration of therapy that the patient needs. If the patient doesn't respond within 4 months of starting Lenalidomide (Lenalid) capsules, the doctor may decide to stop the treatment. It all depends on the response of the patient to the treatment.
The patient will have regular blood tests during treatment with Lenalidomide (Lenalid) capsules. Patient should have their blood tested every week during their first 8 weeks of treatment, and at least monthly after that. The healthcare provider may adjust the dose of Lenalidomide (Lenalid) capsules or interrupt the treatment based on the results of the blood tests and on the patient general condition.